Stock Price
224.71
Daily Change
1.70 0.76%
Monthly
2.06%
Yearly
18.18%
Q1 Forecast
216.14

AbbVie reported $1.86 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 3.35 2.16 Feb/04 2026
FY2025Q3 Sep/2025 1.86 3.26 3.00 Oct/31 2025
FY2025Q2 Jun/2025 2.97 3.21 2.65 Jul/31 2025
FY2025Q1 Mar/2025 2.46 2.57 2.31 Apr/25 2025
FY2024Q4 Dec/2024 2.16 2.06 2.79 Jan/31 2025




Eps Change Date
AbbVie USD 1.86 1.11 Sep/2025
Abbott USD 1.5 0.2 Dec/2025
ALKERMES USD 0.49 0.03 Sep/2025
Amgen USD 5.64 0.38 Sep/2025
AstraZeneca USD 2.38 0.21 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Eisai JPY 36.02 15.33 Sep/2025
Eli Lilly USD 7.02 0.71 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
GlaxoSmithKline GBP 0.55 0.08 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Medtronic USD 1.07 0.08 Sep/2025
Merck USD 2.58 0.45 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.87 0.09 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
UCB EUR 2.44 0.45 Jun/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025
Zoetis USD 1.7 0.06 Sep/2025